Bio-Path Holdings (BPTH) Competitor Comparison
We are evaluating the key criteria listed to compare Bio-Path Holdings (BPTH) against its competitors in the Biotechnology industry.
Market Capitalization
367 / 368Gross Profits
0 / 278Total Revenue
0 / 300EBITDA
71 / 337Free Cashflow
83 / 352Quick Ratio
303 / 357Earnings per Share
343 / 359Dividend yield
0 / 6Total Cash
342 / 358Performance 3 years
250 / 368Performance 5 years
295 / 368Performance 10 years
349 / 368Linearity 3 years
171 / 368Linearity 5 years
250 / 368Linearity 10 years
278 / 366Total Rank
243 / 368Dividend Rank
64 / 368Valuation Rank
346 / 368Piotroski Rank
327 / 368Muliplier Rank
5 / 368Market Capitalization - BPTH ranking 367 / 368
Obligatory risk notice
We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.